Shares of Cencora Inc. COR shed 1.28% to $243.59 Wednesday, on what proved to be an all-around grim trading session for the ...
Walgreens has sold more shares of drug distributor Cencora for proceeds of about $300 million in the latest effort to pay ...
In yet another move to pay down debt that matures in 2026, Walgreens Boots Alliance announced last night it would receive ...
1d
Hosted on MSNCencora Stock Outlook: Is Wall Street Bullish or Bearish?Headquartered in Conshohocken, Pennsylvania, Cencora, Inc. (COR) is a leading pharmaceutical services company dedicated to ...
Outlook Therapeutics, Inc. (Nasdaq: OTLK), a biopharmaceutical company that achieved regulatory approval in the European Union (EU) and the United Kingdom (UK) for the first authorized use of an ...
The sale netted about $300 million for Walgreens and shrinks the company’s stake in Cencora to approximately 6%, down from 10 ...
Leerink Partnrs dropped their Q2 2025 EPS estimates for Cencora in a report released on Wednesday, February 5th. Leerink Partnrs analyst M. Cherny now forecasts that the company will earn $4.08 per ...
Shares of Cencora Inc. COR shed 1.12% to $251.57 Tuesday, on what proved to be an all-around positive trading session for the ...
Cencora Inc (COR) reports a 13% revenue increase and raises full-year guidance, driven by robust US healthcare solutions and ...
Cencora said it intends to repurchase shares from WBA at the price per share equal to the price in the Rule 144 sale.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results